Immucor to Buy BioArray Solutions for $117M | GenomeWeb
NEW YORK (GenomeWeb News) — Diagnostics systems maker Immucor said Tuesday that it will buy molecular diagnostics company BioArray Solutions for around $117 million in cash. 
BioArray has developed diagnostic systems based on its BeadChip system to determine antigens for donors and recipients of blood transfusions. Immucor’s reagents and instruments also are focused on the blood transfusion industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.